the investigators aim to determine the effect of 4 weeks of frequent active breaks from prolonged sitting on time in target glycaemic range in people with type 1 diabetes with high habitual sedentary behaviour.
An open-label randomised controlled trial, whereby participants will complete pre-randomisation baseline procedures before allocation to 4wks of habitual activity (control) or active breaks. Interstitial glucose concentrations (fGM), insulin dose and physical activity/ postural transitions (ActivPAL) will be monitored throughout. To improve generalisability and feasibility of recruiting the required number of participants, the study will be completed in a free-living environment using remote data collection methods.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
118
Participants will be asked to interrupt sitting with 3 min bouts of walking every 30 min from 9am-5pm
Liverpool John Moores University
Liverpool, United Kingdom
RECRUITINGChange in time in target glycaemic range
flash glucose monitoring
Time frame: change from baseline to final week of the intervention
Change in glycaemic variability (coefficient of variation)
flash glucose monitoring
Time frame: change from baseline to final week of the intervention
Change in insulin dose
Insulin dose
Time frame: change from baseline to final week of the intervention
Change in Concentration of Hba1c
HbA1c
Time frame: change from baseline to post intervention (4 weeks)
Change Insulin to CHO ratio
Insulin to CHO ratio
Time frame: change from baseline to post intervention (4 weeks)
Change in Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS)
Time frame: change from baseline to post intervention (4 weeks)
Change in Diabetes Quality of Life
Diabetes Quality of Life (DQOL) questionnaire
Time frame: change from baseline to post intervention (4 weeks)
Change in Health-related quality of life
Short Form-12 Health Survey (SF-12)
Time frame: change from baseline to post intervention (4 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in Height
Height (cm)
Time frame: change from baseline to post intervention (4 weeks)
Change in weight
weight (kg)
Time frame: change from baseline to post intervention (4 weeks)
Change in BMI
BMI
Time frame: change from baseline to post intervention (4 weeks)
Change in waist circumference
waist circumference (cm)
Time frame: change from baseline to post intervention (4 weeks)
Change in triglycerides.
triglycerides.
Time frame: change from baseline to post intervention (4 weeks)
Change in Insulin Sensitivity Score
LogeIS
Time frame: change from baseline to post intervention (4 weeks)
c-peptide
c-peptide
Time frame: baseline
Change in sedentary behaviour
minutes of sitting
Time frame: change from baseline to final week of the intervention
Change in carbohydrate intake
carbohydrate intake
Time frame: change from baseline to final week of the intervention